This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lopez PM et al. (2006) Systematic review: evidence-based management of hepatocellular carcinoma—an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23: 1535–1547
Yao FY et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394–1403
Roayaie S et al. (2002) Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma greater than 5 cm. Ann Surg 235: 533–539
Yao FY et al. (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11: 1505–1514
Lesurtel M et al. (2006) Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 6: 2644–2650
Otto G et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transplant 12: 1260–1267
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Martin, P. Can response to TACE predict survival after liver transplantation in patients with hepatocellular carcinoma?. Nat Rev Gastroenterol Hepatol 4, 540–541 (2007). https://doi.org/10.1038/ncpgasthep0925
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0925